Cypherpunk Technologies Inc. (CYPH)
NASDAQ:CYPH
Want to see CYPH full AI Analyst Report?
CYPH Stock Chart & Stats
$1.13
<$0.01(0.89%)
―
--
Day’s Range― - ―
52-Week Range$0.23 - $3.70
Previous CloseN/A
VolumeN/A
Average Volume (3M)4.08M
Market Cap
$119.24M
Enterprise Value$57.37M
Total Cash (Recent Filing)$6.69M
Total Debt (Recent Filing)$38.00K
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding106,464,485
10 Day Avg. Volume4,753,409
30 Day Avg. Volume4,079,985
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)0.50
Price to Sales (P/S)0.00
P/FCF Ratio-1.75
Enterprise Value/Market Cap0.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.93
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.15
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance Sheet FlexibilityVery low reported debt materially reduces near-term insolvency risk and preserves strategic optionality. This durable balance-sheet flexibility gives management room to raise capital, pursue transactions or withstand operating weakness without immediate leverage-driven constraints.
Orderly Board Refresh / Governance ContinuityAmicable, planned board retirements indicate an orderly governance transition rather than crisis departures. That continuity lowers disruption risk, enables deliberate director succession planning, and supports durable improvements in oversight and strategic alignment over coming months.
Regulatory Clarity / Remediation WindowA defined Nasdaq remediation timeline provides multi-month clarity and a concrete horizon to implement structural fixes (e.g., reverse split, corporate actions). This reduces immediate delisting uncertainty and creates time for management to execute durable compliance or recapitalization steps.
Bears Say
Severe Cash BurnPersistent, large negative operating and free cash flows indicate the business is not self-funding. This sustained cash burn forces reliance on external financing or drastic cost reduction, heightening dilution risk and constraining long-term investment and strategic execution.
Minimal Revenue Vs Large Net LossesA near-zero revenue base paired with very large net losses shows the company has not achieved scalable product-market traction and carries a deeply unprofitable cost structure. Without sustained revenue growth, profitability and margin recovery are unlikely absent major strategic change.
Shareholders' Equity ErosionMaterial decline in shareholders' equity reflects cumulative losses and likely dilution, weakening the capital buffer. This erosion reduces borrowing capacity, limits strategic options, and signals diminished financial resilience over the medium term without recapitalization or sustained profit restoration.
Cypherpunk Technologies News
CYPH FAQ
What was Cypherpunk Technologies Inc.’s price range in the past 12 months?
Cypherpunk Technologies Inc. lowest stock price was $0.23 and its highest was $3.70 in the past 12 months.
What is Cypherpunk Technologies Inc.’s market cap?
Cypherpunk Technologies Inc.’s market cap is $119.24M.
When is Cypherpunk Technologies Inc.’s upcoming earnings report date?
Cypherpunk Technologies Inc.’s upcoming earnings report date is Aug 17, 2026 which is in 78 days.
How were Cypherpunk Technologies Inc.’s earnings last quarter?
Cypherpunk Technologies Inc. released its earnings results on May 14, 2026. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.46.
Is Cypherpunk Technologies Inc. overvalued?
According to Wall Street analysts Cypherpunk Technologies Inc.’s price is currently Undervalued.
Does Cypherpunk Technologies Inc. pay dividends?
Cypherpunk Technologies Inc. does not currently pay dividends.
What is Cypherpunk Technologies Inc.’s EPS estimate?
Cypherpunk Technologies Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cypherpunk Technologies Inc. have?
Cypherpunk Technologies Inc. has 106,464,485 shares outstanding.
What happened to Cypherpunk Technologies Inc.’s price movement after its last earnings report?
Cypherpunk Technologies Inc. reported an EPS of -$0.46 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 15.385%.
Which hedge fund is a major shareholder of Cypherpunk Technologies Inc.?
Currently, no hedge funds are holding shares in CYPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cypherpunk Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 404.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $42.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
202.13%
12-Months-Change
Fundamentals
Return on Equity
-46.86%
Trailing 12-Months
Asset Growth
150.52%
Trailing 12-Months
Company Description
Cypherpunk Technologies Inc.
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.
Ownership Overview
2.33% Insiders
2.12% Mutual Funds
0.28% Other Institutional Investors
93.57% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---